OSL secures distribution agreement for INTRABEAM System

Posted on Aug 15, 2014

Oncology Systems Limited, the largest independent provider of radiotherapy equipment and software in the UK, is delighted to have successfully secured the distribution agreement for the INTRABEAM System within the UK.

The INTRABEAM System, produced by Carl Zeiss, uses intraoperative radiotherapy (IORT) to treat the tumour bed from within, ensuring radiation treatment accuracy.

Neil Roberts, Head of Medical Division, Carl Zeiss Ltd, adds “OSL have established themselves as a well respected provider of oncology products, so were the natural choice for Carl Zeiss Meditec to represent our Intrabeam Intraoperative Radiotherapy system in the UK. We are delighted to be working with OSL at such an exciting time, as we prepare ourselves for the full adoption of this technology in the UK based on the NICE evaluation and initial recommendation”.

This pioneering breast cancer treatment has been in the public eye since draft guidance from the National Institute for Health and Care Excellence (NICE) approved the use of this type of radiotherapy for those in the early stages of the disease.


This page was printed from OSL Web site at http://www.osl.uk.com